Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan

被引:17
|
作者
Ali, Monadil H. [1 ,2 ]
Alrasheedy, Alian A. [3 ]
Hassali, Mohamed Azmi [1 ]
Kibuule, Dan [4 ]
Godman, Brian [1 ,5 ,6 ,7 ]
机构
[1] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Social & Adm Pharm, Minden 11800, Malaysia
[2] Northern Border Univ, Coll Pharm, Dept Clin Pharm, Rafha 91911, Saudi Arabia
[3] Qassim Univ, Unaizah Coll Pharm, Qasim 51911, Saudi Arabia
[4] Univ Namibia, Fac Hlth Sci, Sch Pharm, 340 Mandume Ndemufayo Ave Pioneers Pk, Windhoek 13301, Namibia
[5] Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Clin Pharmacol, Dept Lab Med, SE-14186 Stockholm, Sweden
[6] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland
[7] Sefako Makgatho Hlth Sci Univ, Sch Pharm, ZA-0204 Pretoria, South Africa
来源
ANTIBIOTICS-BASEL | 2019年 / 8卷 / 03期
关键词
MDR-TB; Predictors; Sudan; Tuberculosis; RISK-FACTORS; DRUG-RESISTANCE; PATTERN; STATE;
D O I
10.3390/antibiotics8030090
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Multidrug-resistant tuberculosis (MDR-TB) is a global public health threat and burden on the health system. This is especially the case in high tuberculosis (TB) prevalence countries, such as Sudan. Consequently, this study aimed to ascertain the predictors of MDR-TB in Sudan to provide future guidance. An unmatched case-control study to assess the predictors of MDR-TB infections among the Sudanese population was conducted from August 2017 to January 2018 at Abu-Anga referral hospital. Patients' data was gathered from patients' cards and via interviews. A structured pre-validated questionnaire was used to gather pertinent information, which included sociodemographic characteristics and other relevant clinical data. Univariate and multivariate logistic regression analysis was employed to determine the predictors of MDR-TB infection. 76 of the 183 patients interviewed (41.5%) had MDR-TB cases. The independent predictors for MDR-TB were living in rural areas [adjusted odds ratio (aOR) = 3.1 (95% confidence interval (CI): 1.2-8.2)], treatment failure [aOR = 56.9 (10.2-319.2)], and smoking [(aOR = 4 (1.2-13.2)], whereas other sociodemographic factors did not predict MDR-TB. In conclusion, the study showed that a history of smoking, living in rural areas, and a previous treatment failure were the predictors of MDR-TB in Sudan. The latter factors are most likely due to issues that are related to access and adherence to treatment and lifestyle. The existence of any of these factors among newly diagnosed TB patients should alert clinicians for the screening of MDR-TB. The implementation of directly observed treatment (DOT) and health education are crucial in stopping the spread of MDR-TB in Sudan.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional Study
    Suryavanshi, Nishi
    Murrill, Matthew
    Gupta, Amita
    Hughes, Michael
    Hesseling, Anneke
    Kim, Soyeon
    Naini, Linda
    Jones, Lynne
    Smith, Betsy
    Gupte, Nikhil
    Dawson, Rodney
    Mave, Vidya
    Meshram, Sushant
    Mendoza-Ticona, Alberto
    Sanchez, Jorge
    Kumarasamy, Nagalingeswaran
    Comins, Kyla
    Conradie, Francesca
    Shenje, Justin
    Fontain, Sandy Nerette
    Garcia-Prats, Anthony
    Asmelash, Aida
    Nedsuwan, Supalert
    Mohapi, Lerato
    Lalloo, Umesh
    Garcia Ferreira, Ana Cristina
    Okeyo, Elisha
    Swindells, Susan
    Churchyard, Gavin
    Shah, N. Sarita
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (03) : 436 - 445
  • [42] MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis
    Kendall, Emily A.
    Azman, Andrew S.
    Cobelens, Frank G.
    Dowdy, David W.
    PLOS ONE, 2017, 12 (03):
  • [43] Treatment outcomes and deaths among multidrug-resistant tuberculosis (MDR-TB) patients in Gomel region, Belarus-2009-2010
    Skrahina, Alena
    Khaliaukin, Andrei
    Falzon, Dennis
    Rusovich, Valiantsin
    Dara, Masoud
    Shyrayeu, Aliaksandr
    Zhylevich, Liudmila
    Zignol, Matteo
    Hurevich, Hennadz
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [44] Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) Among Children: Where We Stand Now
    Chowdhury, Kona
    Ahmad, Rahnuma
    Sinha, Susmita
    Dutta, Siddhartha
    Haque, Mainul
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (02)
  • [45] Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB) - a report of ten cases
    von der Lippe, B
    Sandven, P
    Brubakk, O
    JOURNAL OF INFECTION, 2006, 52 (02) : 92 - 96
  • [46] A Bayesian Nonparametric Model for Spatially Distributed Multivariate Binary Data with Application to a Multidrug-Resistant Tuberculosis (MDR-TB) Study
    Kang, Jian
    Zhang, Nanhua
    Shi, Ran
    BIOMETRICS, 2014, 70 (04) : 981 - 992
  • [47] Alcohol use disorders in multidrug resistant tuberculosis (MDR-TB) patients and their non-tuberculosis family contacts in Nigeria
    Lasebikan, Victor Olufolahan
    Ige, Olusoji Mayowa
    PAN AFRICAN MEDICAL JOURNAL, 2020, 36 : 1 - 14
  • [48] Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis (MDR- TB) Compared with Non-MDR-TB Infections in Peninsular Malaysia
    Elmi, Omar Salad
    Hasan, Habsah
    Abdullah, Sarimah
    Jeab, Mat Zuki Mat
    Ba, Zilfalil
    Naing, Nyi Nyi
    MALAYSIAN JOURNAL OF MEDICAL SCIENCE, 2016, 23 (04): : 17 - 25
  • [49] Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective In Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB Isolates
    Kaniga, Kone
    Hasan, Rumina
    Jou, Ruwen
    Vasiliauskiene, Edita
    Chuchottaworn, Charoen
    Ismail, Nazir
    Metchock, Beverly
    Miliauskas, Skaidrius
    Nhung, Nguyen Viet
    Rodrigues, Camilla
    Shin, Soyoun
    Simsek, Hulya
    Smithtikarn, Saijai
    Ngoc, Anh Le Thi
    Boonyasopun, Jirakan
    Kazi, Mubin
    Kim, Seungmo
    Kamolwat, Phalin
    Musteikiene, Greta
    Sacopon, Catherine Ann
    Tahseen, Sabira
    Vasiliauskaite, Laima
    Wu, Mei-Hua
    Omar, Shaheed Vally
    JOURNAL OF CLINICAL MICROBIOLOGY, 2022, 60 (01)
  • [50] Multidrug Resistant Tuberculosis (MDR-TB): Epidemiologic Review and Adverse Events Risk Factors of Anti Tuberculosis Drugs
    Reviono
    Kusnanto, P.
    Eko, Vicky
    Pakiding, Helena
    Nurwidiasih, Dyah
    MAJALAH KEDOKTERAN BANDUNG-MKB-BANDUNG MEDICAL JOURNAL, 2014, 46 (04): : 189 - 196